Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company’s principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally, and the propagation of vegetables and ornamental plants in North America. Its segments include Canadian Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol, IndiMed and CraftPlant. It also has a controlling interest in Bevo Farms Ltd., North America's supplier of propagated vegetables and ornamental plants in North America. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, TerraFarma Inc., Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., among others.


TSX:ACB - Post by User

Bullboard Posts
Post by longonMJon May 19, 2019 5:22pm
85 Views
Post# 29759907

Why Is Oil Extraction Capacity a Constraint w/ CMED Takeover

Why Is Oil Extraction Capacity a Constraint w/ CMED Takeover
Can somebody here please explain why Aurora is saying that they had oile extraction capacity constraints during this past quarter? They seem to be using this as the reason why their revenues on a per gram basis had gone down for this quarter. I found this rather puzzling since I thought the CanniMed takeover from early last year was going to give them access to more CBD oils than they could conceivably sell at this point in time. Ithought CMED's new production line was supposed to be up and running and able to pump out something like 1.2M bottles of high margin CBD oils by the end of 2018. To tell you the honest truth, this number didn't make much sense to me in the first place as this would have been $1.8B in top line revenue per year, based upon a price point of $150 per bottle. Does anybody have any idea of what happened with this supposed CBD oils that CanniMed was going to tuen out for Aurora???
Bullboard Posts